FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 60 filers reported holding FOGHORN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $72,876,191 | -14.3% | 12,674,120 | 0.0% | 8.64% | +54.9% |
Q1 2024 | $85,043,345 | +4.0% | 12,674,120 | 0.0% | 5.58% | -9.6% |
Q4 2023 | $81,748,073 | +29.0% | 12,674,120 | 0.0% | 6.17% | +34.1% |
Q3 2023 | $63,370,600 | -29.0% | 12,674,120 | 0.0% | 4.60% | +15.5% |
Q2 2023 | $89,225,805 | +13.5% | 12,674,120 | 0.0% | 3.98% | +30.4% |
Q1 2023 | $78,579,544 | -2.8% | 12,674,120 | 0.0% | 3.05% | +18.3% |
Q4 2022 | $80,860,886 | -25.6% | 12,674,120 | 0.0% | 2.58% | -43.6% |
Q3 2022 | $108,744,000 | -36.9% | 12,674,120 | 0.0% | 4.58% | -29.5% |
Q2 2022 | $172,368,000 | -10.7% | 12,674,120 | 0.0% | 6.49% | +43.3% |
Q1 2022 | $193,027,000 | -33.4% | 12,674,120 | 0.0% | 4.53% | +1.1% |
Q4 2021 | $289,857,000 | +64.2% | 12,674,120 | 0.0% | 4.48% | +142.3% |
Q3 2021 | $176,551,000 | +30.6% | 12,674,120 | 0.0% | 1.85% | +7.1% |
Q2 2021 | $135,233,000 | -19.0% | 12,674,120 | 0.0% | 1.73% | -35.4% |
Q1 2021 | $167,045,000 | -35.0% | 12,674,120 | 0.0% | 2.68% | -42.8% |
Q4 2020 | $256,905,000 | – | 12,674,120 | – | 4.68% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Capital LLC | 1,261,261 | $10,822,000 | 10.05% |
Flagship Pioneering Inc. | 12,674,120 | $108,744,000 | 4.58% |
Birchview Capital, LP | 264,843 | $2,272,000 | 1.60% |
Artal Group S.A. | 1,720,720 | $14,764,000 | 0.63% |
Rockwood Wealth Management, LLC | 124,030 | $1,064,178 | 0.34% |
Alphabet Inc. | 500,901 | $4,298,000 | 0.22% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 777,525 | $6,671,000 | 0.13% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 330,051 | $2,832,000 | 0.04% |
Virtus ETF Advisers LLC | 8,258 | $71,000 | 0.03% |
Point72 Asset Management, L.P. | 388,600 | $3,334,000 | 0.01% |